Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LTCHNASDAQ:MYPSNASDAQ:SHCRNASDAQ:TOI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLTCHLatch$0.10-4.8%$0.14$0.02▼$0.84$16.48M1.3212,510 shs1,020 shsMYPSPLAYSTUDIOS$1.43+5.6%$1.35$1.14▼$2.46$178.25M0.89218,689 shs95,194 shsSHCRSharecare$1.43$1.43$0.48▼$1.44$531.79M0.512.55 million shsN/ATOIOncology Institute$3.24+0.8%$2.29$0.13▼$3.50$240.66M0.04930,670 shs404,705 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLTCHLatch-2.33%-13.29%-25.00%-41.67%-75.00%MYPSPLAYSTUDIOS+0.75%0.00%+8.00%-17.18%-39.46%SHCRSharecare0.00%0.00%0.00%0.00%+75.46%TOIOncology Institute+2.88%+7.36%+28.40%+276.72%+595.71%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLTCHLatchN/AN/AN/AN/AN/AN/AN/AN/AMYPSPLAYSTUDIOS2.5582 of 5 stars3.34.00.00.02.21.70.6SHCRSharecareN/AN/AN/AN/AN/AN/AN/AN/ATOIOncology Institute1.9529 of 5 stars3.53.00.00.01.51.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLTCHLatch 0.00N/AN/AN/AMYPSPLAYSTUDIOS 2.50Moderate Buy$2.8096.49% UpsideSHCRSharecare 2.00Hold$1.43N/ATOIOncology Institute 3.00Buy$7.00116.38% UpsideCurrent Analyst Ratings BreakdownLatest MYPS, SHCR, LTCH, and TOI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/23/2025MYPSPLAYSTUDIOSCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$2.00 ➝ $3.005/15/2025TOIOncology InstituteBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$7.005/6/2025MYPSPLAYSTUDIOSBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Speculative Buy$2.003/12/2025MYPSPLAYSTUDIOSMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$2.00 ➝ $1.503/11/2025MYPSPLAYSTUDIOSBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLTCHLatch$48.39M0.34N/AN/AN/A∞MYPSPLAYSTUDIOS$274.31M0.65$0.18 per share7.90$2.14 per share0.67SHCRSharecare$445.25M1.19N/AN/A$1.22 per share1.17TOIOncology Institute$403.15M0.61N/AN/A$0.77 per share4.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLTCHLatch-$162.34MN/A0.00∞N/AN/AN/AN/AN/AMYPSPLAYSTUDIOS-$19.39M-$0.24N/A∞17.60-8.75%-9.15%-7.29%8/4/2025 (Estimated)SHCRSharecare-$128.50M-$0.39N/AN/AN/A-33.64%-22.81%-15.96%N/ATOIOncology Institute-$83.07M-$0.70N/A∞N/A-17.63%-186.83%-34.58%8/11/2025 (Estimated)Latest MYPS, SHCR, LTCH, and TOI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025TOIOncology InstituteN/A-$0.18N/A-$0.21N/A$104.41 million5/5/2025Q1 2025MYPSPLAYSTUDIOS-$0.02-$0.02N/A-$0.02$64.45 million$62.71 million3/24/2025Q4 2024TOIOncology Institute-$0.08-$0.14-$0.06-$0.14$109.15 million$100.27 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLTCHLatchN/AN/AN/AN/AN/AMYPSPLAYSTUDIOSN/AN/AN/AN/AN/ASHCRSharecareN/AN/AN/AN/AN/ATOIOncology InstituteN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLTCHLatchN/AN/AN/AMYPSPLAYSTUDIOSN/A4.164.16SHCRSharecareN/A2.022.02TOIOncology Institute5.912.492.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLTCHLatch0.37%MYPSPLAYSTUDIOS37.52%SHCRSharecare35.08%TOIOncology Institute36.86%Insider OwnershipCompanyInsider OwnershipLTCHLatch27.50%MYPSPLAYSTUDIOS14.29%SHCRSharecare30.61%TOIOncology Institute8.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLTCHLatch420164.83 million116.70 millionNo DataMYPSPLAYSTUDIOS510125.08 million106.87 millionOptionableSHCRSharecare3,352371.88 million258.05 millionOptionableTOIOncology Institute66075.56 million68.38 millionNot OptionableMYPS, SHCR, LTCH, and TOI HeadlinesRecent News About These CompaniesInsider Selling: The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells 203,532 Shares of StockMay 23, 2025 | insidertrades.comOncology Institute First Quarter 2025 Earnings: US$0.25 loss per share (vs US$0.22 loss in 1Q 2024)May 16, 2025 | finance.yahoo.comOncology Institute Shares Rise After Higher 1Q RevenueMay 15, 2025 | marketwatch.comThe Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 GuidanceMay 15, 2025 | finanznachrichten.deTOI reaffirms 2025 guidance with $460M–$480M revenue target as capitation contracts fuel growthMay 15, 2025 | msn.comQ1 2025 Oncology Institute Inc Earnings CallMay 15, 2025 | finance.yahoo.comThe Oncology Institute, Inc. (TOI) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comThe Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical OfficerMay 14, 2025 | globenewswire.comTopicus.com Inc. Announces Election of Members of the Board of DirectorsMay 13, 2025 | globenewswire.comThe Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor ConferenceMay 13, 2025 | globenewswire.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Down 5.48%May 10, 2025 | aaii.comConstellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2025May 7, 2025 | globenewswire.comThe Oncology Institute: Insiders Buy Up Big While Valuations Are MurkyMay 6, 2025 | seekingalpha.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Down 6.07%May 5, 2025 | aaii.comThe Oncology Institute, Inc.'s (NASDAQ:TOI) largest shareholders are retail investors with 40% ownership, private equity firms own 24%May 5, 2025 | uk.finance.yahoo.comTopicus.com Inc. Defers Release Date for First Quarter ResultsMay 1, 2025 | globenewswire.comThe Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference CallApril 23, 2025 | globenewswire.comTopicus.com Inc. Announces Release Date for First Quarter ResultsApril 14, 2025 | globenewswire.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 9.33%April 10, 2025 | aaii.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 17.46%April 3, 2025 | aaii.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMYPS, SHCR, LTCH, and TOI Company DescriptionsLatch NASDAQ:LTCH$0.10 -0.01 (-4.76%) As of 09:30 AM EasternLatch, Inc. operates as an enterprise technology company in the United States and Canada. The company offers LatchOS, an operating system that extends smart access, delivery and guest management, smart home and sensors, connectivity, and personalization and services. Its software products include Latch Resident Mobile Applications, Latch Manager Web, and the Latch Manager Mobile Applications. The company also offers hardware devices that include M, C, and R series door-mounted access control products; Latch Intercom, which integrates into the Latch core access systems and allows audio and video calls for remote unlocking; Latch Camera, a dome camera; Latch Hub, a connectivity solution that enables smart access, smart home, and sensor devices at various buildings; and Latch Leak Detector, a solution to enable leak prevention, detection, and resolution for building owners and residents. In addition, it provides NFC unlock on Android that allows the user to unlock their door without even opening their phone; Latch Visitor Express, a contactless visitor entry system; and LatchID, an identification system. The company is headquartered in New York, New York.PLAYSTUDIOS NASDAQ:MYPS$1.42 +0.08 (+5.56%) As of 12:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.PLAYSTUDIOS, Inc. develops and publishes free-to-play casual games for mobile and social platforms in the United States and internationally. The company's game portfolio includes a diverse range of titles comprising social casino, card, puzzle, and adventure games. It also offers POP! Slots, myVEGAS Slots, my KONAMI Slots, MGM Slots Live, myVEGAS Blackjack, myVEGAS Bingo, Tetris, Solitaire, Spider Solitaire, Jumbline 2, Sudoku, and Mahjong games. PLAYSTUDIOS, Inc. is headquartered in Las Vegas, Nevada.Sharecare NASDAQ:SHCRSharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being. It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health. In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities. It sells its solutions through direct sales organization and partner relationships. Sharecare, Inc. was founded in 2009 and is headquartered in Atlanta, Georgia.Oncology Institute NASDAQ:TOI$3.24 +0.03 (+0.78%) As of 12:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Archer Aviation Stock Steadies After Short-Seller Report e.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal Apple Stock Could Rally After Tariffs Are Blocked By Court Hormel Stock Near Lows, But Tariff Relief Could Boost Outlook Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
